Clinical Trial Update: Evaluation of Long-term Safety and Effectiveness of Fostamatinib in the Treatment of Rheumatoid Arthritis (RA) [Phase 3]

View source ↗

Summary

Phase 3 evaluation of fostamatinib for rheumatoid arthritis was terminated. Results from the terminated long-term safety and effectiveness study were posted in …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Fostamatinib (fostamatinib)

Snippet

Sponsor: AstraZeneca | Conditions: Rheumatoid Arthritis | Phase 3 | Status: TERMINATED | Results posted: 2014-04-04